EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole- N -phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors

Shohreh Bakhshi Varzaneh, Mohammad Hosein Sayahi, Mohammad Halimi, Seyedeh Niloufar Ghafouri, Navid Dastyafteh, Somayeh Mojtabavi iD, Bagher Larijani, Maryam Mohammadi-Khanaposhtani iD, Mohammad Mahdavi

RSC Advances · 2026 · 16 (36) · 38429-38441

DOI: 10.1039/d6ra03078e ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Shohreh Bakhshi Varzaneh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran Iran. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Babol University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of thirteen new 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole- N -phenylacetamide) derivatives 8a–m were synthesized as potent α-glucosidase inhibitors.

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences Tehran Iran.
  • Department of Chemistry, Payame Noor University Tehran Iran.
  • Department of Biology, Babol Branch, Islamic Azad University Babol Iran.
  • School of Chemistry, College of Science, University of Tehran Tehran Iran.
  • Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences Tehran Iran.
  • Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center, Tehran University of Medical Sciences Tehran Iran.

ORCID-Profile: Somayeh Mojtabavi, Maryam Mohammadi-Khanaposhtani

Förderung

  • Babol University of Medical Sciences

Zitieren

APA

Bakhshi Varzaneh, S., Sayahi, M. H., Halimi, M., Ghafouri, S. N., Dastyafteh, N., Mojtabavi, S., Larijani, B., Mohammadi-Khanaposhtani, M., & Mahdavi, M. (2026). Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole- N -phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors. RSC Advances, 16(36), 38429-38441. https://doi.org/10.1039/d6ra03078e

Vancouver

Bakhshi Varzaneh S, Sayahi MH, Halimi M, Ghafouri SN, Dastyafteh N, Mojtabavi S, et al. Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole- N -phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors. RSC Advances. 2026;16(36):38429-38441. doi:10.1039/d6ra03078e

BibTeX
@article{BakhshiVarzaneh2026,
  author = {Bakhshi Varzaneh, Shohreh and Sayahi, Mohammad Hosein and Halimi, Mohammad and Ghafouri, Seyedeh Niloufar and Dastyafteh, Navid and Mojtabavi, Somayeh and Larijani, Bagher and Mohammadi-Khanaposhtani, Maryam and Mahdavi, Mohammad},
  title = {Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole- N -phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {36},
  pages = {38429--38441},
  doi = {10.1039/d6ra03078e}
}
Kostenlos starten →